Methods for Assessing Percutaneous Absorption the Report and Recommendations of ECVAM Workshop 13

ATLA Alternatives to Laboratory Animals

Volumn 24, Issue 1, 1996, Pages 81-106

  Howes, Doug ^a   Guy, Richard ^b   Hadgraft, Jonathan ^c   Heylings, Jon ^d   Hoeck, Ulla ^e   Kemper, Fritz ^f   Maibach, Howard ^g   Marty, Jean Paul ^h   Merk, Hans ⁱ   Parra, José ^j   Rekkas, Dimitrios ^k   Rondelli, Ivano ^l   Schaefer, Hans ^m   Täuber, Ulrich ⁿ   Verbiese, Nicole ^o  

^a UNILEVER RESEARCH   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d ASTRAZENECA   (United Kingdom)

^e PFIZER INC   (United States)

^f UNIVERSITY OF MUNICH   (Germany)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITÉ PARIS SACLAY   (France)

ⁱ UNIVERSITY OF COLOGNE   (Germany)

^j DEPT OF ENVIRONMENTAL CHEMISTRY   (Spain)

^k UNIVERSITY OF ATHENS   (Greece)

^l CHIESI FARMACEUTICI S P A   (Italy)

^m Galderma R and D   (France)

ⁿ BAYER PHARMA AG   (Germany)

^o Dow Corning SA Belgium   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030043351     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (78)

1. Anon. (1994). ECVAM News & Views. ATLA 22, 7-11.
2. Anon. (1994). Proposal for Two New Guidelines on Percutaneous Absorption. OECD Environ-mental Health and Safety Division Discussion Document, ref. ENV/EHS/HK/ mc/94.103, 18 pp. Paris: OECD.
3. Skelly, J.P., Shah, V.P., Maibach, H.I., Guy, R.H., Wester, R.C., Flynn, G. & Yacobi, A. (1987). FDA and AAPS report of the workshop on principles and practices of in vitro percutaneous penetration studies. relevance to bioavailability and bioequivalence Pharmaceutical Research 4, 265-267.
4. Anon. (1992). Dermal Exposure Assessment: Principles and Application. US Department of Commerce, Environmental Protection Agency Report No. EPA/600/8-91 011B, 450 pp Washington, DC: US Department of Commerce.
5. Anon (1993). Subdivision F Hazard Evaluation - Humans and domestic animals: proposed new guideline section 85-3. Dermal absorption studies of pesticides. Federal Register 58,202, 54,350.
6. Albery, W J. & Hadgraft, J. (1979) Percutaneous absorption: in vivo experiments. Journal of Pharmacy and Pharmacology 31, 140-147.
7. Potts, R.O. & Francoeur, M. (1991) The influence of stratum corneum morphology on water permeability. Journal of Investigative Dermatology 96, 495-499.
8. Nemanic, M.K. & Elias, P.M. (1980). In situ precipitation: a novel cytochemical technique for visualisation of permeability pathways in mammalian stratum corneum. Journal of Histochemistry and Cytochemistry 28, 573-578.
9. Wertz, P.W. (1992). Epidermal lipids. Seminars in Dermatology 11, 106-113.
10. Potts, R.O. & Francoeur, M. (1992). Physical methods for studying stratum corneum lipids. Seminars in Dermatology 11, 129-138.
11. Golden, G.M., Mackie, J.E. & Potts, R.O. (1987). The role of stratum corneum fluidity in transdermal drug flux. Journal of Pharmaceutical Science 76, 25-28.
12. Ongpipattanakul, B., Burnette, R.R., Potts, R.O. & Francoeur, M.L. (1991). Evidence that oleic acid exists in a separate phase within the stratum corneum lipids. Pharmaceutical Research 8, 350-354.
13. Bouwstra, J.A., de Vries, M.A., Gooris, G.S., Bras, W., Brussee, J. & Ponec, M. (1991). Thermodynamic and structural aspects of the skin barrier. Journal of Controlled Release 15, 209-219.
14. Swartzendruber, D.C. (1992). Studies of epidermal lipids using electron microscopy. Seminars in Dermatology 11, 157-161.
15. Guy, R.H. & Hadgraft, J. (1985). The prediction of plasma levels of drugs following transdermal application. Journal of Controlled Release 1, 177-182.
16. Potts, R.O. & Guy, R.H. (1990). Predicting skin permeability. Pharmaceutical Research 9, 663-669
17. Guy, R.H. & Hadgraft, J. (1988). Physicochemical aspects of percutaneous penetration and its enhancement. Pharmaceutical Research 5, 753-758
18. Guy, R.H. & Hadgraft, J. (1982). Percutaneous metabolism with saturable enzyme kinetics. International Journal of Pharmacology 11, 187-197.
19. Hueber, F., Schaefer, H. & Wepierre, J (1994). Role of transepidermal and transfollicular routes in percutaneous absorption of steroids: in vitro studies on human skin. Skin Pharmacology 7, 237-244.
20. Rolland, A , Wagner, N., Chatelus, A., Shroot, B. & Schaefer, H. (1993). Site-specific drug delivery to pilosebaceous structures using polymeric microspheres. Pharmaceutical Research 10, 1738-1744.
21. Cullander, C. & Guy, R.H. (1991). Visualising the pathways of iontophoretic current flow in real time with laser scanning confocal microscopy and the vibrating probe electrode. Percutaneous penetration enhancers: mode of action. In Prediction of Percutaneous Penetration. Vol. 2 (ed. R.C. Scott, R.H. Guy, J. Hadgraft & H.E. Boddé), pp. 229-237. London: IBC Technical Services.
22. Guy, R.H., Mak, V.H.W, Kai, T., Bommannan, D. & Potts, R.O. (1990). Percutaneous penetration enhancers: mode of action. In Prediction of Percutaneous Penetration, Vol. 1 (ed. R.C. Scott, R.H. Guy & J. Hadgraft), pp. 213-223. London: IBC Technical Services.
23. Watkinson, A.C., Bunge, A.L., Hadgraft, J. & Naik, A. (1992). Computer simulation of penetrant concentration-depth profiles in the stratum corneum. International Journal of Pharmacology 87, 175-182.
24. Kasting, G.B., Smith, R.L. & Cooper, E.R. (1987). Effect of lipid solubility and molecular size on percutaneous absorption. In Pharmacology and the Skin, Vol. 1, Skin Pharmacokinetics (ed. B. Shroot & H. Schaefer), pp. 138-153. Basel: Karger.
25. Flynn, G.L. (1990). Physicochemical determinants of skin absorption. In Principles of Routeto-Route Extrapolation for Risk Assessment (ed. T.R. Gerrity & C.J. Henry), pp. 93-127. New York: Elsevier.
26. Pugh, W.J. & Hadgraft, J. (1994). Ab initio prediction of human skin permeability coefficients. International Journal of Pharmacology 103, 163-178.
27. Hansch, C. & Leo, A.J. (1979). Substituent Constants for Correlation Analysis in Chemistry and Biology, 339 pp. New York: Wiley.
28. Hadgraft, J., Cordes, G. & Wolff, M. (1990). Prediction of the transdermal delivery of ß-blockers. In Die Haut als Transportorgan für Arzneistoffe (ed. N. Rietbrock), pp. 133-143. Darmstadt, Germany: Steinkopff Verlag.
29. Kemppainen, B.W & Reifenrath, W.G., eds (1990). Methods for Skin Absorption, 219 pp. Boca Raton: CRC Press.
30. Anon. (1993). Percutaneous Absorption. ECETOC Monograph No. 20, 80pp. Brussels: ECETOC.
31. Marco, G.J., Simoneaux, B.J., Williams, S C., Cassidy, J.E., Bissig, R. & Muecke, W. (1985). Radiotracer approaches to rodent dermal studies In Dermal Exposure Related to Pesticide Use. Discussion of Risk Assessment (ed. R.C. Honeycutt, G. Zweig & N.N. Ragsdale), p. 43. Washington, DC: American Chemical Society.
32. Anon. (1982). World Medical Association: Proposed International Guidelines for Biochemical Research Involving Human Subjects, 88 pp. Geneva: WHO
33. Anon. (1991). Declaration of Helsinki, revised version (October 1983). In Good Clinical Practice in Europe (ed. M.E. Allen), pp. 73-76. Romford, UK. Rostrum.
34. Anon. (1977). Use of Ionising Radiation and Radionucleides on Human Beings for Medicinal, Research, Training and Non-medical Purposes. WHO Technical Report Series, No. 611. 41 pp. Geneva WHO.
35. Anon. (1977). Recommendations of the International Commission on Radiological Protection. ICRP Publication 26. 75 pp. Oxford: Pergamon Press.
36. Anon. (1988). National Radiological Protection Board - Guidance Notes for the Protection of Persons Against Ionising Radiations Arising from Medical and Dental Use, 87 pp. London: HMSO.
37. Yano, T., Nakagawa, A., Tsuji, M. & Noda, K. (1986) Skin permeability of various non-steroidal anti-inflammatory drugs in man. Life Sciences 39, 1043-1050.
38. Guy, R.H., Bucks, D.A.W., McMaster, J.R., Villaflor, D.A., Roskos, K.V., Hin, R.S. & Maibach, H.I. (1987). Kinetics of drug absorption across human skin in vivo. Developments in methodology. In Pharmacology and the Skin, Vol. 1, Skin Pharmacokinetics (ed. B. Shroot & H. Schaefer), pp. 70-76. Basel: Karger.
39. Higo, N., Naik, A., Bommannan, D.B., Potts, R.O. & Guy, R.H. (1993). Validity of reflectance infra-red spectroscopy. Pharmaceutical Research 10, 1500-1506.
40. Mak, V.H.W., Potts, R.O. & Guy, R.H. (1990). Percutaneous penetration enhancement in vivo measured by attenuated total reflectance infrared spectroscopy. Pharmaceutical Research 7, 835-841.
41. Wingen, F., Gloxhuber, C. & Holtmann, W. (1983). Screening - Untersuchungen zur Frage der Hautresorption von Kosmetikfarbstoffen: Parts 1 and 2. Journal of the Society of Cosmetic Chemists 34, 47-54.
42. Tojo, K. & Lee, A.C. (1989). A method for predicting steady-state rate of skin penetration in vivo. Journal of Investigative Dermatology 92, 105-110.
43. Dupuis, D., Rougier, A., Roguet, R., Lotte, C. & Kalopissis, G. (1984). In vivo relationship between horny layer reservoir effect and percutaneous absorption in human and rat. Journal of Investigative Dermatology 82, 353-358.
44. Rougier, A., Dupuis, D. & Lotte, C. (1989). Stripping method for measuring percutaneous absorption in vivo. In Percutaneous Absorption: Mechanisms-Methodology-Drug Delivery, 2nd edn (ed. R.L. Bronaugh & H.I. Maibach), pp. 415-434. New York: Marcel Dekker.
45. Rougier, A. (1990). Predictive measurement of in vivo percutaneous absorption. In Prediction of Percutaneous Penetration: Methods, Measurements and Modelling (ed. R.C. Scott, R.H. Guy & J. Hadgraft•), pp. 252-262. London: IBC Technical Services.
46. Rougier, A. & Lotte, C. (1993). Predictive approaches. I. The stripping technique. In Topical Drug Unavailability, Bioequivalence and Penetration (ed. V.P. Shah & H.I. Maibach), pp. 163-181. New York: Plenum Press.
47. Barry, B.W. (1983). Dermatological formulations. Percutaneous absorption. In Drugs and the Pharmaceutical Sciences, Vol. 18 (ed. J. Swarbrick), pp. 234-295 New York: Marcel Dekker.
48. Barry, B.W. (1989). Optimising percutaneous absorption. In Percutaneous Absorption: Mechanisms-Methodology-Drug Delivery, 2nd edn (ed. R.L. Bronaugh & H.I. Maibach), pp. 531-554. New York: Marcel Dekker
49. Queille-Roussel, C., Poncet, M. & Schaefer, H. (1991). Quantification of skin colour changes induced by topical corticosteroid preparations using the Minolta Chroma Meter. British Journal of Dermatology 124, 264-270.
50. Bronaugh, R.L., Stewart, R.F. & Congdon, E.R. (1982). Methods for in vitro absorption studies. II. Animal models for human skin. Toxicology and Applied Pharmacology 62, 481-488.
51. Bronaugh, R.L. & Maibach, H.I (1985). Percutaneous absorption of nitroaromatic comunds: in vivo and in vitro studies in human and monkey skin. Journal of Investigative Dermatology 84, 180-183.
52. Franz, T.J. (1975). In vitro vs in vivo percutaneous absorption: on the relevance of in vitro data. Journal of Investigative Dermatology 64, 190-195.
53. Grissom, R.E. Jr, Brownie, C. & Guthrie, F.E. (1987). In vivo and in vitro dermal penetration of lipophilic and hydrophilic pesticides in mice. Bulletin of Environmental Contamination and Toxicology 38, 917-924.
54. Hotchkiss, S.A., Chidgey, M.A.J., Rose, S. & Caldwell, J. (1990). Percutaneous absorption of benzyl acetate through rat skin in vitro. I. Validation of an in vitro model against in vivo data. Food and Chemical Toxicology 28, 443-448.
55. Ramsey, J.D., Woollen, B.H., Auton, T.R., Batten, P.L & Leeser, J.E. (1990). Percutaneous absorption of the lipophilic herbicide fluazifopbutyl in man. In Prediction of Percutaneous Penetration: Methods, Measurements and Modelling (ed. R.C. Scott, R.H. Guy & J. Hadgraft), pp. 49-57. London: IBC Technical Services
56. Scott, R.C., Batten, P.L., Clowes, H.M., Jones, B.K. & Ramsey, J.D. (1992). Further validation of an in vitro method to reduce the need for in vivo studies for measuring the absorption of chemicals through the skin. Fundamental and Applied Toxicology 19, 484-492.
57. Yang, J.J., Roy, T.A., Kruger, A.J., Neil, W. & Mackerer, C.R. (1989). In vitro and in vivo percutaneous absorption of benzo[a]pyrene from petroleum crude-fortified soil in the rat Bulletin of Environmental Contamination and Toxicology 43, 207-214.
58. Rougier, A. (1990). Predictive measurement of in vivo percutaneous absorption In Prediction of Percutaneous Penetration: Methods, Measurements and Modelling (ed. R.C. Scott, R.H. Guy & J. Hadgraft), pp. 19-33. London: IBC Technical Services.
59. Rutherford, T. & Black, J.G. (1969) The use of autoradiography to study the localisation of germicides in skin. British Journal of Dermatology 81, Suppl. 4, 75-79.
60. Schaefer, H., Zesch, A. & Stuettgen, G., eds (1982). Skin Permeability, 541pp. Berlin: Springer Verlag.
61. Bartek, M.J., La Budde, J.A. & Maibach, H.I. (1972). Skin permeability in vivo: comparison in rat, rabbit, pig and man. Journal of Investigative Dermatology 58, 114-123.
62. Scott, R.C, Walker, M.W. & Dugard, P.H. (1987). A comparison of the in vitro permeability properties of human and some laboratory animal skins. International Journal of Cosmetic Science 8, 189-194.
63. Monteiro-Rivere, N.A. (1990). Specialized technique: the isolated perfused porcine skin flap (IPPSF) In Methods for Skin Absorption (ed. B.W. Kemppainen & W.G. Reifenrath). p 175. Boca Raton, FL, USA: CRC Press
64. Celleste, L., Marratzu, C , Valote, M., Scagarli, G. & Carti, P. (1992). The single-pass perfused rabbit ear as a model for studying percutaneous absorption of clonazepam. I. General characteristics. Methods and Findings in Experimental and Clinical Pharmacology 149, 701-706.
65. de Lange, J., van Eck, P., Elliot, G.R., de Kort, L.A M. & Wolthuis, O.L. (1992). The isolated blood-perfused pig ear: an inexpensive and animal-saving model for skin penetration studies. Journal of Pharmacology and Toxicology Methods 27, 71-77.
66. Bronaugh, R.L. & Collier, S.W. (1991). Protocol for in vitro percutaneous absorption studies. In In Vitro Percutaneous Absorption: Principles, Fundamentals and Applications (ed. R.L. Bronaugh & H.I Maibach), pp. 237-241. Boca Raton, FL, USA: CRC Press.
67. Scott, R.C & Clowes, H.M. (1992). In vitro percutaneous absorption experiments: a guide to the technique for use in toxicology assessments. Toxicology Methods 2, 113-123.
68. Mukhtar, H. & Khan, W.A. (1989). Cutaneous cytochrome P450. Drug Metabolism Reviews 20, 657-673.
69. Hotchkiss, S.A. (1990). Skin as a xenobiotic metabolising organ In Progress in Drug Metabolism, Vol. 13 (ed. G.G. Gibson), pp. 217-262. London: Taylor & Francis.
70. Pendlington, R.U., Williams, D.L., Naik, J.T. & Sharma, R.K. (1994). Distribution of xenobiotic metabolising enzymes in skin. Toxicology in Vitro 8, 525-527
71. Elias, P.M. & Menon, G.K. (1991). Structural and lipid correlates of the epidermal permeability barrier. Advances in Lipid Research 24, 1-10.
72. Forestier, J.P. (1992). Les enzymes de l'espace extra cellulaire du stratum corneum. International Journal of Cosmetic Science 14, 47-63.
73. Suzuki, Y., Nomura, J., Hori, J., Koyama, J., Takahashi, M., & Horii, I. (1993). Detection and characterisation of endogenous protease associated with desquamation of stratum corneum. Archives of Dermatology Research 283, 108-112.
74. Boehnliein, J., Sakr, A., Lichtin, J L. & Bronaugh, R.L. (1994). Characterisation of esterase and alcohol dehydrogenase activity in skin. Metabolism of retinol palmitate to retinol (Vitamin A) during percutaneous absorption. Pharmaceutical Research 11, 1155-1159.
75. Collier, S.W., Sale, M.E., Gastonguay, M.R., Bronaugh, R.L. & Schwartz, S.L. (1993). Role of stratum corneum, viable epidermis and saturable metabolism on percutaneous penetration of phenylazophenol. Pharmaceutical Research 10, S412.
76. Bronaugh, R.L. & Stewart, R.F. (1984). Methods for in vitro percutaneous absorption studies. III. Hydrophobic compounds. Journal of Pharmaceutical Science 73, 1255-1259.
77. Fisher, H.L., Shah, P.V., Sumler, M.R. & Hall, L.L. (1989). In vivo and in vitro dermal penetration of 2,4,5,2′,4′,5′-hexachlorobiphenyl in young and adult rats. Environmental Research 50, 120-139.
78. Ramsey, J.D., Woollen, B.H., Auton, T.R. & Scott, R.C. (1994). The predictive accuracy of in vitro measurements for the dermal absorption of a lipophilic penetrant (fluazifop-butyl) through rat and human skin. Fundamental and Applied Toxicology 23, 230-236.